mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |